Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial Article

Li, Erfeng, Wang, Jie, Guo, Bin et al. (2025). Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial . Frontiers in Cellular and Infection Microbiology, 15 10.3389/fcimb.2025.1616066

Open Access

cited authors

  • Li, Erfeng; Wang, Jie; Guo, Bin; Zhang, Wenbin

sustainable development goals

authors

publication date

  • June 12, 2025

published in

keywords

  • BIFIDOBACTERIUM
  • BUTYRATE
  • HEALTH
  • Immunology
  • Intestinal barrier function (IBF)
  • Irritable bowel syndrome (IBS)
  • LACTOBACILLUS
  • Life Sciences & Biomedicine
  • MICROBIOTA
  • Microbiology
  • Probiotics
  • Science & Technology
  • Short-chain fatty acids (SCFA)
  • double-blind randomized controlled trial (DBRCT)

Digital Object Identifier (DOI)

publisher

  • FRONTIERS MEDIA SA

volume

  • 15